Division of Histopathology and Cytopathology
Histopathology: Pediatric tumours, liver pathology, skin pathology, immunohistochemistry as applicable for diagnosis of various types of malignancy and gallbladder neoplasia.
Division of Haematology
Haematology: Anaemia with special reference to heamolytic anaemia, leukemias and Bleeding & coagulation disorders especially investigating hemophilia and allied disorders along with recent investigation on idiopathic thrombophilia.

Division of Immunopathology

(a) In Autoimmunity research is going on rheumatic diseases, autoimmune thyroid and hepatic disease
(b) Tumour marker especially in Carcinoma Prostate, Hepatoma, Carcinoma Lung, GIT and Gall Bladder Carcinoma and Multiple Myeloma.
(c) Transplantation immunology - Tissue typing and cytokines are being done, Infectious diseases.
(d) Immunohistochemistry

PLAN OF ACTION

Division of Histopathology and Cytopathology

• Histopathology and Cytology sections efforts for establishing Immuno-histochemistry for the diseases of undifferentiated tumours and Lymphomas is going on.

Division of Haematology

• Enhancement of leukemia research by starting immuno-phenotyping and cytogenetics, which is prerequisite for bone marrow transplantation.
  
• High performance liquid chromatographic studies (HPLC studies) for variant hemogloinopathies.
  
• Bleeding and coagulation disorders with special reference to Antiphospholipid antibodies and Hypercoagulable states.

Division Of Immunopathology

• Immunopathology unit has planned to develop molecular Immunopathology for diagnosis of tumour, and infectious disease and tissue typing for solid order transplantation by PCR and for seeing the molecular variation in HLA antigen by PCR in various diseases.
  
• Immunophenotype of lymphocyte in diagnosis of immunodeficiency diseases by flow cytometry and cross matched test by flow cytometry which is more sensitive method for renal transplantation.
  
• Development of automatic ELISA test by automatic ELISA reader.
  
• Development of myeloma typing by immunofixation for routine testing.